Publications
Export 109 results:
Filters: Author is M-A Roy [Clear All Filters]
“[Detecting and Treating Comorbid Disorders in First-Episode Psychosis: A Lever for Recovery].”, Sante Ment Que, vol. 46, no. 2, pp. 307-330, 2021.
“[Early Intervention for Psychosis from Past to Future: Overcoming Implementation Challenges to Maximize its Impact?].”, Sante Ment Que, vol. 46, no. 2, pp. 391-415, 2021.
“[Family Approaches in Early Intervention: Benchmarks to Guide Intervention and Support Families in First Episode Psychosis Programs (FEPP)].”, Sante Ment Que, vol. 46, no. 2, pp. 139-159, 2021.
“[From Kraepelin to McGorry: Scientific Vision and Experiential Narrative around a Major Paradigmatic Shift].”, Sante Ment Que, vol. 46, no. 2, pp. 23-43, 2021.
“[A Healthy Mind in a Healthy Body: The Value of Physical Activity for Youth With First Episode Psychosis].”, Sante Ment Que, vol. 46, no. 2, pp. 249-276, 2021.
“[Not Available].”, Sante Ment Que, vol. 46, no. 2, pp. 19-21, 2021.
, “Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program.”, CNS Drugs, vol. 35, no. 4, pp. 461-468, 2021.
“[Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery].”, Sante Ment Que, vol. 46, no. 2, pp. 113-137, 2021.
, “Urbanicity, Schizophrenia and Equitable Specialist Services Allocation.”, Can J Psychiatry, p. 7067437211040606, 2021.
, “Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics.”, World J Biol Psychiatry, pp. 1-8, 2020.
, “The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017.”, Can J Psychiatry, vol. 65, no. 7, pp. 510-511, 2020.
, “From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs).”, Expert Rev Neurother, 2020.
, “A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds.”, Eur J Hum Genet, vol. 28, no. 4, pp. 499-507, 2020.
, “Personalized cognitive remediation therapy to facilitate return to work or to school in recent-onset psychosis.”, Neurocase, vol. 26, no. 6, pp. 340-352, 2020.
, “Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports.”, J Clin Psychopharmacol, vol. 40, no. 2, pp. 191-194, 2020.
, “"Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients.”, Psychopharmacology (Berl), 2020.
, “Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence.”, J Clin Psychopharmacol, vol. 39, no. 4, pp. 393-397, 2019.
, “Determinants of occupational outcome in recent-onset psychosis: The role of cognition.”, Schizophr Res Cogn, vol. 18, p. 100158, 2019.
, “[Long-acting antipsychotics: The QAAPAPLE algorithm review].”, Can J Psychiatry, p. 706743719847193, 2019.
, “Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use.”, Asian J Psychiatr, 2018.
, “Effects of Antiparkinson Medication on Cognition in Parkinson's Disease: A Systematic Review.”, Can J Neurol Sci, vol. 45, no. 4, pp. 375-404, 2018.
, “More intensive probing increases the detection of social anxiety disorders in schizophrenia.”, Psychiatry Res, vol. 268, pp. 358-360, 2018.
, “Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity.”, J Psychiatry Neurosci, vol. 43, no. 4, pp. 287-288, 2018.
, “Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin.”, Sci Rep, vol. 7, no. 1, p. 5238, 2017.
